Literature DB >> 19854451

Elevated monocytes in patients with critical limb ischemia diminish after bypass surgery.

Dania Magri1, Penny Vasilas, Akihito Muto, Tamara N Fitzgerald, Tiffany T Fancher, Aaron J Feinstein, Toshiya Nishibe, Alan Dardik.   

Abstract

BACKGROUND: Mononuclear cells (MNC) increase neovascularization and ulcer healing after injection into an ischemic extremity. Circulating MNC are composed of lymphocytes (85%), monocytes (15%), and endothelial progenitor cells (EPC; 0.03%). We hypothesized that ischemic limbs secrete paracrine signals to recruit bone marrow-derived monocytes and EPC into the circulation, such that patients with critical limb ischemia (CLI) have increased circulating monocytes compared with control patients. We also hypothesized that circulating monocytes and EPC recruitment decrease after resolution of ischemia with successful revascularization.
METHODS: We reviewed the records of all patients at the VA Connecticut Healthcare System undergoing primary, functionally successful, lower extremity peripheral bypass surgery between 2002 and 2007, but only including patients with both preoperative and postoperative (>4 mo) complete blood counts with differentials.
RESULTS: Patients with CLI (n = 24) had elevated preoperative monocyte counts compared with control patients (n = 8) (0.753 ± 0.04 versus 0.516 ± 0.05; P = 0.0046), whereas the preoperative lymphocyte counts were not significantly different. After revascularization, ischemic patients had decreased monocyte counts compared with control patients (-20% versus + 55%; P = 0.0003), although lymphocyte counts were unchanged in both groups. Diabetic patients also had reduced postoperative monocyte counts (-32% versus + 13%; P = 0.035). Multivariable logistic regression demonstrated that the only factor that independently predicted reduced postoperative monocyte count was preoperative CLI (P = 0.038).
CONCLUSIONS: Patients with CLI have increased numbers of circulating monocytes, and the monocyte number decreases with resolution of ischemia after successful revascularization. Circulating monocytes may be a clinically useful perioperative marker in patients with CLI undergoing vascular surgery.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19854451      PMCID: PMC2895962          DOI: 10.1016/j.jss.2009.06.014

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  18 in total

1.  Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II).

Authors:  L Norgren; W R Hiatt; J A Dormandy; M R Nehler; K A Harris; F G R Fowkes
Journal:  J Vasc Surg       Date:  2007-01       Impact factor: 4.268

2.  Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial.

Authors:  Eriko Tateishi-Yuyama; Hiroaki Matsubara; Toyoaki Murohara; Uichi Ikeda; Satoshi Shintani; Hiroya Masaki; Katsuya Amano; Yuji Kishimoto; Kohji Yoshimoto; Hidetoshi Akashi; Kazuyuki Shimada; Toshiji Iwasaka; Tsutomu Imaizumi
Journal:  Lancet       Date:  2002-08-10       Impact factor: 79.321

3.  Strikingly different angiogenic properties of endothelial progenitor cell subpopulations: insights from a novel human angiogenesis assay.

Authors:  Daniel P Sieveking; Andrew Buckle; David S Celermajer; Martin K C Ng
Journal:  J Am Coll Cardiol       Date:  2008-02-12       Impact factor: 24.094

4.  New insights on endothelial progenitor cell subpopulations and their angiogenic properties.

Authors:  Eduard Shantsila; Timothy Watson; Hung-Fat Tse; Gregory Y H Lip
Journal:  J Am Coll Cardiol       Date:  2008-02-12       Impact factor: 24.094

5.  Autologous mononuclear stem cell transplantation in patients with peripheral occlusive arterial disease.

Authors:  Thomas Bartsch; Michael Brehm; Tobias Zeus; Bodo-Eckehard Strauer
Journal:  J Cardiovasc Nurs       Date:  2006 Nov-Dec       Impact factor: 2.083

6.  Short-term intra-arterial infusion of monocyte chemoattractant protein-1 results in sustained collateral artery growth.

Authors:  Randolph W Seidler; Martin C Lenter; Brian D Guth; Henri Doods
Journal:  J Cardiovasc Pharmacol Ther       Date:  2007-03       Impact factor: 2.457

Review 7.  Endothelial progenitor cells: a promising therapeutic alternative for cardiovascular disease.

Authors:  Chunming Dong; Pascal J Goldschmidt-Clermont
Journal:  J Interv Cardiol       Date:  2007-04       Impact factor: 2.279

8.  Transplantation of autologous mononuclear bone marrow stem cells in patients with peripheral arterial disease (the TAM-PAD study).

Authors:  T Bartsch; M Brehm; T Zeus; G Kögler; P Wernet; B E Strauer
Journal:  Clin Res Cardiol       Date:  2007-08-17       Impact factor: 5.460

9.  Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization.

Authors:  C Kalka; H Masuda; T Takahashi; W M Kalka-Moll; M Silver; M Kearney; T Li; J M Isner; T Asahara
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-28       Impact factor: 11.205

10.  Monocyte chemoattractant protein-1 in patients with peripheral arterial disease.

Authors:  Jana Petrkova; Jaroslava Szotkowska; Zuzana Hermanova; Jan Lukl; Martin Petrek
Journal:  Mediators Inflamm       Date:  2004-02       Impact factor: 4.711

View more
  4 in total

1.  Simvastatin inhibits inflammation in ischemia-reperfusion injury.

Authors:  Yilin Zhao; Qingzhao Feng; Zhengjie Huang; Wenpeng Li; Baisheng Chen; Long Jiang; Binglin Wu; Weiji Ding; Gang Xu; Heng Pan; Wei Wei; Weiyuan Luo; Qi Luo
Journal:  Inflammation       Date:  2014-10       Impact factor: 4.092

Review 2.  Cell-based interventions for therapeutic angiogenesis: review of potential cell sources.

Authors:  Robert A Brenes; Mackenzie Bear; Caroline Jadlowiec; Matthew Goodwin; Peter Hashim; Clinton D Protack; Kenneth R Ziegler; Xin Li; Lynn S Model; Wei Lv; Michael J Collins; Alan Dardik
Journal:  Vascular       Date:  2012-10-19       Impact factor: 1.285

3.  Fucoidan Stimulates Monocyte Migration via ERK/p38 Signaling Pathways and MMP9 Secretion.

Authors:  Elene Sapharikas; Anna Lokajczyk; Anne-Marie Fischer; Catherine Boisson-Vidal
Journal:  Mar Drugs       Date:  2015-06-30       Impact factor: 5.118

4.  Monocyte-to-Lymphocyte Ratio as a Predictor of Worse Long-Term Survival after Off-Pump Surgical Revascularization-Initial Report.

Authors:  Tomasz Urbanowicz; Michał Michalak; Anna Olasińska-Wiśniewska; Anna Witkowska; Michał Rodzki; Ewelina Błażejowska; Aleksandra Gąsecka; Bartłomiej Perek; Marek Jemielity
Journal:  Medicina (Kaunas)       Date:  2021-12-03       Impact factor: 2.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.